These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30582507)

  • 1. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
    Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.
    Sota J; Vitale A; Rigante D; Orlando I; Lucherini OM; Simpatico A; Lopalco G; Franceschini R; Galeazzi M; Frediani B; Fabiani C; Tosi GM; Cantarini L
    Isr Med Assoc J; 2018 Aug; 20(8):517-521. PubMed ID: 30084580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
    Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
    Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
    Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
    Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
    Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
    Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
    van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA
    Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
    Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
    J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.
    Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G
    Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid-A in Behçet's disease.
    Vitale A; Rigante D; Lopalco G; Brizi MG; Caso F; Franceschini R; Denaro R; Galeazzi M; Punzi L; Iannone F; Lapadula G; Simpatico A; Marrani E; Costa L; Cimaz R; Cantarini L
    Clin Rheumatol; 2014 Aug; 33(8):1165-7. PubMed ID: 24659331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement.
    Bassyouni IH; Sharaf M; Wali IE; Mansour HM
    Heart Vessels; 2016 Jun; 31(6):918-24. PubMed ID: 25964071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.